data_1cwx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cwx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.322 0.582 . . . . 10.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.491 ' HD2' ' HB3' ' A' ' 24' ' ' PRO . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . . . . . . 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.59 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.686 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.524 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.656 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.276 0.56 . . . . 10.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.635 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.489 ' O ' ' C ' ' A' ' 23' ' ' PHE . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 2' ' ' THR . 9.6 t -179.9 89.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 10.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -130.01 82.44 66.32 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 10.0 109.534 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 35.9 Cg_endo -78.14 -60.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.61 2.207 . . . . 10.0 110.442 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 164.29 -51.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.819 . . . . 10.0 109.661 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -77.63 149.49 26.91 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.164 1.91 . . . . 10.0 110.448 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.74 -21.64 18.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 10.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -89.16 147.59 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.822 . . . . 10.0 109.479 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 12.9 tptm 179.45 -49.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 10.0 109.347 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.71 -80.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 10.0 109.489 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -41.62 -61.3 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 10.0 109.802 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER 63.23 -174.8 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 10.0 109.396 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' ARG . 82.8 m-20 -45.02 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 10.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 10.0 109.719 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.11 150.97 39.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.968 . . . . 10.0 109.618 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' CG1' HG23 ' A' ' 33' ' ' VAL . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.579 ' CA ' ' HB ' ' A' ' 29' ' ' ILE . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.646 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . 165.44 100.44 0.15 Allowed Glycine 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.531 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.14 -10.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.093 -1.24 . . . . 10.0 110.421 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.579 ' HB ' ' CA ' ' A' ' 22' ' ' LYS . 0.6 OUTLIER 80.37 -6.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.373 -0.829 . . . . 10.0 109.428 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.588 ' C ' ' CE1' ' A' ' 34' ' ' TYR . 59.6 t -107.22 14.54 7.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.261 -0.975 . . . . 10.0 108.805 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -131.35 -25.34 0.8 Allowed Glycine 0 N--CA 1.485 1.957 0 C-N-CA 118.971 -1.585 . . . . 10.0 111.876 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 35' ' ' LEU . . . -81.7 -24.96 54.86 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 117.549 -2.262 . . . . 10.0 109.659 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 21.0 t -74.23 -10.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 105.848 -1.908 . . . . 10.0 105.848 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 17.3 m-85 -104.66 -12.96 16.12 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.0 -1.454 . . . . 10.0 107.228 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.583 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 16.4 mt -90.52 6.05 45.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 9.1 mt -90.5 -44.91 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 115.418 -0.81 . . . . 10.0 112.15 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.1 Cg_endo -78.61 -56.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.512 2.141 . . . . 10.0 111.214 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 9.5 ptp180 -86.12 29.04 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 10.0 110.189 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.029 -1.044 . . . . 10.0 109.368 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 38' ' ' ARG . . . 75.71 74.43 0.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.79 -5.42 13.91 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.806 2.338 . . . . 10.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -116.34 102.82 9.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 10.0 109.459 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.1 mp -128.8 18.88 6.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 10.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.997 -1.446 . . . . 10.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 2' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.58 . . . . 10.0 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.425 ' HB ' ' O ' ' A' ' 1' ' ' SER . 31.9 m 59.98 -89.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 10.0 109.486 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 1' ' ' SER . 22.5 t30 -164.66 84.54 1.16 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 10.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.59 69.29 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.735 2.29 . . . . 10.0 110.476 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -78.97 -53.27 1.15 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 10.0 109.937 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' CB ' ' A' ' 5' ' ' LYS . 35.8 Cg_endo -78.52 159.86 28.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.465 2.11 . . . . 10.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -102.42 111.44 23.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 10.0 109.258 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 51.66 67.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 10.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 10' ' ' THR . 9.7 tttt -173.71 149.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.818 . . . . 10.0 109.247 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 9' ' ' LYS . 1.3 m -155.85 146.19 21.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 10.0 109.658 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 12' ' ' ARG . 88.7 tttt -173.05 -53.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 10.0 109.358 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 11' ' ' LYS . 10.5 mmt180 61.86 129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 10.0 109.542 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -131.31 139.41 49.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 10.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 15' ' ' ASN . 15.3 t -170.67 -43.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 10.0 109.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.487 ' N ' HG21 ' A' ' 14' ' ' THR . 25.0 t30 -164.65 116.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 10.0 109.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.59 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.686 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.686 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.67 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.571 ' O ' ' CG1' ' A' ' 29' ' ' ILE . 2.5 tt0 -101.52 -13.85 17.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.335 -1.097 . . . . 10.0 110.62 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.571 ' CG1' ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER 83.26 -12.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.596 ' C ' ' CE1' ' A' ' 34' ' ' TYR . 48.5 t -92.92 16.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.22 -0.925 . . . . 10.0 108.857 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.92 -14.64 1.63 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.165 -1.493 . . . . 10.0 111.489 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.729 ' HA2' ' HB3' ' A' ' 35' ' ' LEU . . . -88.58 -24.56 32.93 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.202 -1.951 . . . . 10.0 109.39 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.542 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 13.6 t -76.67 -10.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.532 -2.025 . . . . 10.0 105.532 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 13.1 m-85 -103.34 -6.85 21.56 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.016 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.729 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -91.25 -2.6 57.41 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 16.9 mt -82.88 -45.0 0.89 Allowed Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.41 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.4 Cg_endo -80.13 -51.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.523 2.149 . . . . 10.0 109.975 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 39.25 0.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.329 -0.857 . . . . 10.0 109.449 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 -48.42 -24.8 1.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.273 -0.892 . . . . 10.0 109.02 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.72 98.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.594 -1.402 . . . . 10.0 109.594 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.54 166.1 26.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.481 2.121 . . . . 10.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -103.12 -14.76 16.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 10.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.84 67.04 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 10.0 109.49 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.022 -1.432 . . . . 10.0 109.542 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p -92.24 72.9 5.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 10.0 109.48 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -176.65 96.18 0.24 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 10.0 109.379 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 35.3 Cg_endo -77.43 151.35 29.24 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.584 2.19 . . . . 10.0 110.528 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 106.12 47.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 10.0 109.434 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 4' ' ' PRO . 35.1 Cg_endo -77.47 124.34 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.365 2.043 . . . . 10.0 110.468 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 81.74 8.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 10.0 109.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 118.71 32.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 10.0 109.35 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -150.93 -90.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 10.0 109.638 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 9' ' ' LYS . 3.3 m 79.96 -73.36 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.748 . . . . 10.0 109.586 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 62.59 127.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 10.0 109.612 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER 50.47 -179.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 10.0 109.497 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -149.98 -66.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 10.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 14' ' ' THR . 51.3 m -124.05 78.87 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 10.0 109.543 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -115.16 101.85 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 10.0 109.246 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.575 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.451 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.559 ' CA ' ' HB ' ' A' ' 29' ' ' ILE . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.656 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.46 67.21 0.21 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -135.02 18.59 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.553 -0.969 . . . . 10.0 109.299 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' HB ' ' CA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -54.78 -28.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.459 0.647 . . . . 10.0 109.368 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.543 ' C ' ' CE1' ' A' ' 34' ' ' TYR . 48.7 t -84.59 16.03 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 C-N-CA 118.459 -1.297 . . . . 10.0 110.538 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.484 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -141.39 -27.65 0.18 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.836 -1.173 . . . . 10.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.598 ' HA3' ' CZ ' ' A' ' 23' ' ' PHE . . . -80.35 -19.88 68.1 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 117.777 -2.154 . . . . 10.0 108.929 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 ' HA ' ' CD1' ' A' ' 36' ' ' LEU . 40.3 t -73.95 -11.17 14.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.512 -2.032 . . . . 10.0 105.512 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 21.5 m-85 -103.62 -16.15 15.59 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.872 -1.513 . . . . 10.0 107.073 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 30.7 mt -90.45 4.26 51.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.621 ' HB2' ' HD3' ' A' ' 37' ' ' PRO . 16.6 mt -76.79 -45.54 3.06 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.907 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 36' ' ' LEU . 35.6 Cg_endo -78.22 -54.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.403 2.069 . . . . 10.0 110.281 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -87.44 23.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 10.0 109.879 -179.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -50.06 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 10.0 109.515 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' ARG . . . 44.61 89.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.33 179.31 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.544 2.163 . . . . 10.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 3.82 35.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 10.0 109.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.26 58.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 10.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.966 -1.463 . . . . 10.0 109.506 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.9 m -157.98 -74.63 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 10.0 109.461 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -52.56 152.77 6.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 10.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.93 -2.99 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.646 2.231 . . . . 10.0 110.449 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 14.9 mttm 61.44 79.68 0.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 10.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.97 134.15 12.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.629 2.219 . . . . 10.0 110.429 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -90.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 10.0 109.42 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.09 99.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 10.0 109.416 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -163.13 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 10.0 109.535 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER 174.71 172.92 0.22 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.939 . . . . 10.0 109.292 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -58.2 177.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 10.0 109.47 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.6 98.75 1.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 10.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.84 -63.71 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 10.0 109.34 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.512 ' O ' ' CG2' ' A' ' 14' ' ' THR . 8.8 t -141.14 81.29 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.818 . . . . 10.0 109.34 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -47.39 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 10.0 109.622 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.635 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.628 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.613 ' O ' ' CB ' ' A' ' 29' ' ' ILE . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.61 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 -97.65 1.79 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.568 ' O ' ' CG1' ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.95 -33.67 0.84 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.368 -1.078 . . . . 10.0 110.954 -178.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.613 ' CB ' ' O ' ' A' ' 22' ' ' LYS . 0.7 OUTLIER 85.34 -12.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.604 ' C ' ' CE1' ' A' ' 34' ' ' TYR . 61.5 t -98.04 18.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -128.28 -23.34 1.27 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.035 -1.555 . . . . 10.0 111.988 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 35' ' ' LEU . . . -82.8 -26.46 45.64 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 117.686 -2.197 . . . . 10.0 109.991 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 17.5 t -73.51 -9.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 12.6 m-85 -105.41 -15.65 14.96 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.86 -1.518 . . . . 10.0 106.907 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.63 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 10.1 mt -91.46 6.93 43.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.612 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 19.4 mt -78.78 -45.22 1.88 Allowed Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.231 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.7 Cg_endo -77.22 -100.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.089 1.859 . . . . 10.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' CG ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -94.72 -106.04 0.14 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 120.768 -1.208 . . . . 10.0 109.461 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -106.96 -17.15 14.26 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 121.345 -0.847 . . . . 10.0 109.346 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.6 78.34 1.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.353 -1.499 . . . . 10.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 35.6 Cg_endo -78.24 157.68 29.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.647 2.232 . . . . 10.0 110.542 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.5 104.28 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 10.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 5.6 mp -118.71 61.15 0.79 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 10.0 109.517 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.449 -1.46 . . . . 10.0 109.449 -179.963 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.322 0.582 . . . . 10.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' A' ' 24' ' ' PRO . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . . . . . . 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 21' ' ' VAL . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.688 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.653 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.276 0.56 . . . . 10.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.653 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 24' ' ' PRO . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 2' ' ' THR . 9.6 t -179.9 89.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 10.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -130.01 82.44 66.32 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 10.0 109.534 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 35.9 Cg_endo -78.14 -60.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.61 2.207 . . . . 10.0 110.442 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 164.29 -51.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.819 . . . . 10.0 109.661 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -77.63 149.49 26.91 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.164 1.91 . . . . 10.0 110.448 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.74 -21.64 18.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 10.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -89.16 147.59 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.822 . . . . 10.0 109.479 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 12.9 tptm 179.45 -49.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 10.0 109.347 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.71 -80.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 10.0 109.489 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -41.62 -61.3 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 10.0 109.802 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER 63.23 -174.8 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 10.0 109.396 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' ARG . 82.8 m-20 -45.02 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 10.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 10.0 109.719 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.11 150.97 39.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.968 . . . . 10.0 109.618 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 33' ' ' VAL . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . 165.44 100.44 0.15 Allowed Glycine 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.14 -10.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.093 -1.24 . . . . 10.0 110.421 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.833 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER 80.37 -6.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.373 -0.829 . . . . 10.0 109.428 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.6 t -107.22 14.54 7.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.261 -0.975 . . . . 10.0 108.805 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -131.35 -25.34 0.8 Allowed Glycine 0 N--CA 1.485 1.957 0 C-N-CA 118.971 -1.585 . . . . 10.0 111.876 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.909 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -81.7 -24.96 54.86 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 117.549 -2.262 . . . . 10.0 109.659 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 21' ' ' VAL . 21.0 t -74.23 -10.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 105.848 -1.908 . . . . 10.0 105.848 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 17.3 m-85 -104.66 -12.96 16.12 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.0 -1.454 . . . . 10.0 107.228 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD12 ' HA2' ' A' ' 32' ' ' GLY . 16.4 mt -90.52 6.05 45.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 9.1 mt -90.5 -44.91 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 115.418 -0.81 . . . . 10.0 112.15 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.1 Cg_endo -78.61 -56.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.512 2.141 . . . . 10.0 111.214 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 9.5 ptp180 -86.12 29.04 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 10.0 110.189 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.029 -1.044 . . . . 10.0 109.368 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' O ' HD11 ' A' ' 43' ' ' LEU . . . 75.71 74.43 0.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.79 -5.42 13.91 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.806 2.338 . . . . 10.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -116.34 102.82 9.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 10.0 109.459 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' O ' ' A' ' 40' ' ' GLY . 1.1 mp -128.8 18.88 6.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 10.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.997 -1.446 . . . . 10.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.431 ' O ' ' HB ' ' A' ' 2' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.58 . . . . 10.0 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 31.9 m 59.98 -89.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 10.0 109.486 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' THR . 22.5 t30 -164.66 84.54 1.16 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 10.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.59 69.29 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.735 2.29 . . . . 10.0 110.476 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -78.97 -53.27 1.15 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 10.0 109.937 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 5' ' ' LYS . 35.8 Cg_endo -78.52 159.86 28.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.465 2.11 . . . . 10.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -102.42 111.44 23.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 10.0 109.258 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 51.66 67.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 10.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 10' ' ' THR . 9.7 tttt -173.71 149.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.818 . . . . 10.0 109.247 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 9' ' ' LYS . 1.3 m -155.85 146.19 21.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 10.0 109.658 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' ARG . 88.7 tttt -173.05 -53.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 10.0 109.358 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' LYS . 10.5 mmt180 61.86 129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 10.0 109.542 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.31 139.41 49.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 10.0 109.475 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 15' ' ' ASN . 15.3 t -170.67 -43.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 10.0 109.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' N ' HG23 ' A' ' 14' ' ' THR . 25.0 t30 -164.65 116.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 10.0 109.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 21' ' ' VAL . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.688 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HA ' HG22 ' A' ' 29' ' ' ILE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.67 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 29' ' ' ILE . 2.5 tt0 -101.52 -13.85 17.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.335 -1.097 . . . . 10.0 110.62 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER 83.26 -12.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 30' ' ' VAL . 48.5 t -92.92 16.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.22 -0.925 . . . . 10.0 108.857 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.92 -14.64 1.63 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.165 -1.493 . . . . 10.0 111.489 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' ' 35' ' ' LEU . . . -88.58 -24.56 32.93 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.202 -1.951 . . . . 10.0 109.39 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 13.6 t -76.67 -10.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.532 -2.025 . . . . 10.0 105.532 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 13.1 m-85 -103.34 -6.85 21.56 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.016 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -91.25 -2.6 57.41 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 16.9 mt -82.88 -45.0 0.89 Allowed Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.41 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.4 Cg_endo -80.13 -51.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.523 2.149 . . . . 10.0 109.975 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 39.25 0.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.329 -0.857 . . . . 10.0 109.449 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 -48.42 -24.8 1.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.273 -0.892 . . . . 10.0 109.02 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.72 98.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.594 -1.402 . . . . 10.0 109.594 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.54 166.1 26.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.481 2.121 . . . . 10.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -103.12 -14.76 16.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 10.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.84 67.04 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 10.0 109.49 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.022 -1.432 . . . . 10.0 109.542 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p -92.24 72.9 5.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 10.0 109.48 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -176.65 96.18 0.24 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 10.0 109.379 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 35.3 Cg_endo -77.43 151.35 29.24 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.584 2.19 . . . . 10.0 110.528 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 106.12 47.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 10.0 109.434 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 4' ' ' PRO . 35.1 Cg_endo -77.47 124.34 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.365 2.043 . . . . 10.0 110.468 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 81.74 8.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 10.0 109.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 118.71 32.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 10.0 109.35 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -150.93 -90.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 10.0 109.638 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 9' ' ' LYS . 3.3 m 79.96 -73.36 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.748 . . . . 10.0 109.586 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 62.59 127.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 10.0 109.612 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER 50.47 -179.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 10.0 109.497 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -149.98 -66.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 10.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 14' ' ' THR . 51.3 m -124.05 78.87 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 10.0 109.543 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -115.16 101.85 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 10.0 109.246 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' CA ' ' HB ' ' A' ' 29' ' ' ILE . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.653 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.46 67.21 0.21 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -135.02 18.59 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.553 -0.969 . . . . 10.0 109.299 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -54.78 -28.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.459 0.647 . . . . 10.0 109.368 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 30' ' ' VAL . 48.7 t -84.59 16.03 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 C-N-CA 118.459 -1.297 . . . . 10.0 110.538 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -141.39 -27.65 0.18 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.836 -1.173 . . . . 10.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -80.35 -19.88 68.1 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 117.777 -2.154 . . . . 10.0 108.929 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' HD11 ' A' ' 36' ' ' LEU . 40.3 t -73.95 -11.17 14.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.512 -2.032 . . . . 10.0 105.512 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 21.5 m-85 -103.62 -16.15 15.59 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.872 -1.513 . . . . 10.0 107.073 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD12 ' HA2' ' A' ' 32' ' ' GLY . 30.7 mt -90.45 4.26 51.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 16.6 mt -76.79 -45.54 3.06 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.907 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 35.6 Cg_endo -78.22 -54.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.403 2.069 . . . . 10.0 110.281 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -87.44 23.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 10.0 109.879 -179.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -50.06 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 10.0 109.515 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' ARG . . . 44.61 89.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.33 179.31 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.544 2.163 . . . . 10.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 3.82 35.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 10.0 109.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.26 58.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 10.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.966 -1.463 . . . . 10.0 109.506 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.9 m -157.98 -74.63 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 10.0 109.461 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -52.56 152.77 6.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 10.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.93 -2.99 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.646 2.231 . . . . 10.0 110.449 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 14.9 mttm 61.44 79.68 0.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 10.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.97 134.15 12.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.629 2.219 . . . . 10.0 110.429 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -90.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 10.0 109.42 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.09 99.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 10.0 109.416 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 10' ' ' THR . 3.3 tttt -163.13 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 10.0 109.535 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 174.71 172.92 0.22 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.939 . . . . 10.0 109.292 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -58.2 177.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 10.0 109.47 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.6 98.75 1.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 10.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.84 -63.71 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 10.0 109.34 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 14' ' ' THR . 8.8 t -141.14 81.29 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.818 . . . . 10.0 109.34 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -47.39 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 10.0 109.622 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.653 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 29' ' ' ILE . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.64 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 -97.65 1.79 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.822 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.95 -33.67 0.84 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.368 -1.078 . . . . 10.0 110.954 -178.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER 85.34 -12.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.691 ' O ' HG12 ' A' ' 30' ' ' VAL . 61.5 t -98.04 18.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -128.28 -23.34 1.27 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.035 -1.555 . . . . 10.0 111.988 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -82.8 -26.46 45.64 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 117.686 -2.197 . . . . 10.0 109.991 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 17.5 t -73.51 -9.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 12.6 m-85 -105.41 -15.65 14.96 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.86 -1.518 . . . . 10.0 106.907 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.894 HD12 ' HA2' ' A' ' 32' ' ' GLY . 10.1 mt -91.46 6.93 43.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 19.4 mt -78.78 -45.22 1.88 Allowed Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.231 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 36.7 Cg_endo -77.22 -100.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.089 1.859 . . . . 10.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.47 ' CG ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -94.72 -106.04 0.14 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 120.768 -1.208 . . . . 10.0 109.461 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -106.96 -17.15 14.26 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 121.345 -0.847 . . . . 10.0 109.346 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.6 78.34 1.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.353 -1.499 . . . . 10.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.401 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 35.6 Cg_endo -78.24 157.68 29.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.647 2.232 . . . . 10.0 110.542 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.5 104.28 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 10.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 5.6 mp -118.71 61.15 0.79 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 10.0 109.517 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.449 -1.46 . . . . 10.0 109.449 -179.963 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.322 0.582 . . . . 10.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' O ' ' CE1' ' A' ' 23' ' ' PHE . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' A' ' 24' ' ' PRO . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . . . . . . 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.0 t30 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.075 -0.713 . . . . 10.0 109.075 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 21' ' ' VAL . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.521 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.688 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.246 -0.649 . . . . 10.0 109.246 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.513 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.653 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.276 0.56 . . . . 10.0 109.622 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.653 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.493 ' HD2' ' HB3' ' A' ' 24' ' ' PRO . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 23' ' ' PHE . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.483 -0.562 . . . . 10.0 109.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 2' ' ' THR . 9.6 t -179.9 89.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.224 -0.922 . . . . 10.0 109.462 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t30 -130.01 82.44 66.32 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 10.0 109.534 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 5' ' ' LYS . 35.9 Cg_endo -78.14 -60.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.61 2.207 . . . . 10.0 110.442 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 164.29 -51.52 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.389 -0.819 . . . . 10.0 109.661 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -77.63 149.49 26.91 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.164 1.91 . . . . 10.0 110.448 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -94.74 -21.64 18.61 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 10.0 109.439 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -89.16 147.59 24.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.384 -0.822 . . . . 10.0 109.479 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 12.9 tptm 179.45 -49.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 10.0 109.347 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -85.71 -80.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.314 -0.866 . . . . 10.0 109.489 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -41.62 -61.3 1.11 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.525 -0.734 . . . . 10.0 109.802 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.453 ' O ' ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER 63.23 -174.8 0.15 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.158 -0.964 . . . . 10.0 109.396 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 12' ' ' ARG . 82.8 m-20 -45.02 169.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 10.0 109.473 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.66 -38.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -0.925 . . . . 10.0 109.719 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -119.11 150.97 39.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.968 . . . . 10.0 109.618 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.661 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -79.84 -178.66 6.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.297 -0.877 . . . . 10.0 109.335 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.661 ' CB ' ' O ' ' A' ' 16' ' ' ARG . 21.6 tpp180 120.76 -45.57 0.0 OUTLIER Pre-proline 0 N--CA 1.504 2.248 0 N-CA-C 109.238 -0.653 . . . . 10.0 109.238 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 17' ' ' ARG . 36.6 Cg_endo -82.59 -24.89 3.32 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 C-N-CA 122.18 1.92 . . . . 10.0 108.548 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -86.71 41.26 0.94 Allowed 'General case' 0 C--N 1.283 -2.283 0 CA-C-O 123.126 1.441 . . . . 10.0 110.555 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.39 -43.16 0.08 Allowed 'General case' 0 C--N 1.253 -3.621 0 CA-C-N 113.705 -1.588 . . . . 10.0 108.801 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG12 HG22 ' A' ' 33' ' ' VAL . 5.6 t -76.97 2.23 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 117.994 -1.482 . . . . 10.0 109.927 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.819 ' O ' HG22 ' A' ' 29' ' ' ILE . 5.5 ptpt -102.09 7.77 40.99 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.667 ' N ' ' CD1' ' A' ' 23' ' ' PHE . 55.0 m-85 43.4 68.4 3.0 Favored Pre-proline 0 C--N 1.3 -1.549 0 CA-C-O 123.349 1.547 . . . . 10.0 107.593 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.641 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 39.0 Cg_endo -75.69 150.94 35.92 Favored 'Trans proline' 0 C--N 1.294 -2.312 0 C-N-CA 124.812 3.675 . . . . 10.0 110.531 -177.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 56.55 68.41 1.71 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.801 -1.719 . . . . 10.0 108.801 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.91 67.5 0.91 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.868 -1.693 . . . . 10.0 108.868 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 23' ' ' PHE . . . 165.44 100.44 0.15 Allowed Glycine 0 C--O 1.211 -1.323 0 N-CA-C 106.938 -2.465 . . . . 10.0 106.938 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.814 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -48.14 -10.28 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.093 -1.24 . . . . 10.0 110.421 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.833 ' O ' HD12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER 80.37 -6.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.373 -0.829 . . . . 10.0 109.428 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 30' ' ' VAL . 59.6 t -107.22 14.54 7.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.261 -0.975 . . . . 10.0 108.805 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -131.35 -25.34 0.8 Allowed Glycine 0 N--CA 1.485 1.957 0 C-N-CA 118.971 -1.585 . . . . 10.0 111.876 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.909 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -81.7 -24.96 54.86 Favored Glycine 0 N--CA 1.487 2.087 0 C-N-CA 117.549 -2.262 . . . . 10.0 109.659 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.862 HG22 HG12 ' A' ' 21' ' ' VAL . 21.0 t -74.23 -10.73 14.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 N-CA-C 105.848 -1.908 . . . . 10.0 105.848 175.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.682 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 17.3 m-85 -104.66 -12.96 16.12 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.0 -1.454 . . . . 10.0 107.228 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.909 HD12 ' HA2' ' A' ' 32' ' ' GLY . 16.4 mt -90.52 6.05 45.19 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 176.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.604 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 9.1 mt -90.5 -44.91 0.4 Allowed Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 115.418 -0.81 . . . . 10.0 112.15 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.1 Cg_endo -78.61 -56.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.512 2.141 . . . . 10.0 111.214 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 9.5 ptp180 -86.12 29.04 0.76 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.105 -0.997 . . . . 10.0 110.189 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.77 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.029 -1.044 . . . . 10.0 109.368 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.513 ' O ' HD11 ' A' ' 43' ' ' LEU . . . 75.71 74.43 0.91 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.471 -1.452 . . . . 10.0 109.471 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.79 -5.42 13.91 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.806 2.338 . . . . 10.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -116.34 102.82 9.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.294 -0.879 . . . . 10.0 109.459 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD11 ' O ' ' A' ' 40' ' ' GLY . 1.1 mp -128.8 18.88 6.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 10.0 109.564 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 CA-C-O 117.997 -1.446 . . . . 10.0 109.524 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.431 ' O ' ' HB ' ' A' ' 2' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.435 -0.58 . . . . 10.0 109.435 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 3' ' ' ASN . 31.9 m 59.98 -89.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 10.0 109.486 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.513 ' N ' HG22 ' A' ' 2' ' ' THR . 22.5 t30 -164.66 84.54 1.16 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.253 -0.904 . . . . 10.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.59 69.29 7.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.735 2.29 . . . . 10.0 110.476 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -78.97 -53.27 1.15 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.18 -0.95 . . . . 10.0 109.937 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 5' ' ' LYS . 35.8 Cg_endo -78.52 159.86 28.72 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.465 2.11 . . . . 10.0 110.588 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -102.42 111.44 23.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.367 -0.833 . . . . 10.0 109.258 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 mtm180 51.66 67.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.282 -0.886 . . . . 10.0 109.27 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.474 ' HG3' ' N ' ' A' ' 10' ' ' THR . 9.7 tttt -173.71 149.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.818 . . . . 10.0 109.247 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 9' ' ' LYS . 1.3 m -155.85 146.19 21.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.207 -0.933 . . . . 10.0 109.658 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' O ' ' A' ' 12' ' ' ARG . 88.7 tttt -173.05 -53.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.35 -0.844 . . . . 10.0 109.358 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.439 ' O ' ' O ' ' A' ' 11' ' ' LYS . 10.5 mmt180 61.86 129.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 10.0 109.542 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -131.31 139.41 49.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 10.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 15' ' ' ASN . 15.3 t -170.67 -43.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -0.91 . . . . 10.0 109.338 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' N ' HG23 ' A' ' 14' ' ' THR . 25.0 t30 -164.65 116.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.386 -0.821 . . . . 10.0 109.075 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' O ' ' CD ' ' A' ' 17' ' ' ARG . 12.3 mtm180 -82.21 174.7 10.94 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.236 -0.915 . . . . 10.0 109.942 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' CB ' ' HD3' ' A' ' 18' ' ' PRO . 0.3 OUTLIER 161.42 -57.26 0.0 OUTLIER Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 17' ' ' ARG . 37.1 Cg_endo -79.94 -23.61 6.55 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.421 2.081 . . . . 10.0 107.607 177.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.6 OUTLIER -91.27 43.99 1.17 Allowed 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 113.574 -1.648 . . . . 10.0 109.967 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -151.52 -39.98 0.12 Allowed 'General case' 0 C--N 1.251 -3.711 0 CA-C-N 113.522 -1.672 . . . . 10.0 108.903 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 21' ' ' VAL . 57.9 t -78.16 3.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 117.812 -1.555 . . . . 10.0 110.004 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.521 ' CD ' ' HB3' ' A' ' 24' ' ' PRO . 10.2 ptpt -104.64 2.61 30.74 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 106.962 -1.495 . . . . 10.0 106.962 177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.688 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 66.2 m-85 46.65 66.97 4.86 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-O 123.474 1.607 . . . . 10.0 106.947 -178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.848 ' HA ' HG22 ' A' ' 29' ' ' ILE . 40.2 Cg_endo -77.21 -72.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.294 -2.316 0 C-N-CA 124.722 3.615 . . . . 10.0 110.185 -177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -49.85 -23.42 5.21 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.967 -1.653 . . . . 10.0 108.967 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.12 -71.62 0.64 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.215 -1.554 . . . . 10.0 109.215 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.67 -89.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.69 -1.243 . . . . 10.0 110.057 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.793 ' O ' HG23 ' A' ' 29' ' ' ILE . 2.5 tt0 -101.52 -13.85 17.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.335 -1.097 . . . . 10.0 110.62 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER 83.26 -12.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 N-CA-C 109.514 -0.55 . . . . 10.0 109.514 -179.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 ' O ' HG12 ' A' ' 30' ' ' VAL . 48.5 t -92.92 16.15 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.22 -0.925 . . . . 10.0 108.857 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.92 -14.64 1.63 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.165 -1.493 . . . . 10.0 111.489 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.763 ' HA2' ' HB3' ' A' ' 35' ' ' LEU . . . -88.58 -24.56 32.93 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 118.202 -1.951 . . . . 10.0 109.39 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 13.6 t -76.67 -10.4 13.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 105.532 -2.025 . . . . 10.0 105.532 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.681 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 13.1 m-85 -103.34 -6.85 21.56 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.945 -1.479 . . . . 10.0 107.016 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.877 ' O ' HD12 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -91.25 -2.6 57.41 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 106.296 -1.742 . . . . 10.0 106.296 176.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' N ' ' CD ' ' A' ' 37' ' ' PRO . 16.9 mt -82.88 -45.0 0.89 Allowed Pre-proline 0 N--CA 1.485 1.314 0 CA-C-N 115.713 -0.676 . . . . 10.0 111.41 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 36' ' ' LEU . 36.4 Cg_endo -80.13 -51.35 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.523 2.149 . . . . 10.0 109.975 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.58 39.25 0.87 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.329 -0.857 . . . . 10.0 109.449 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 -48.42 -24.8 1.37 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.273 -0.892 . . . . 10.0 109.02 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 55.72 98.98 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.594 -1.402 . . . . 10.0 109.594 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.54 166.1 26.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.481 2.121 . . . . 10.0 110.289 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -103.12 -14.76 16.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.274 -0.891 . . . . 10.0 109.618 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.84 67.04 3.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 10.0 109.49 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.022 -1.432 . . . . 10.0 109.542 179.877 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.52 -0.548 . . . . 10.0 109.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 p -92.24 72.9 5.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.268 -0.895 . . . . 10.0 109.48 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -176.65 96.18 0.24 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 10.0 109.379 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.47 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 35.3 Cg_endo -77.43 151.35 29.24 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.584 2.19 . . . . 10.0 110.528 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.51 106.12 47.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.345 -0.847 . . . . 10.0 109.434 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 4' ' ' PRO . 35.1 Cg_endo -77.47 124.34 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.365 2.043 . . . . 10.0 110.468 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.89 81.74 8.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 10.0 109.655 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.67 118.71 32.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 10.0 109.35 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 10' ' ' THR . 0.0 OUTLIER -150.93 -90.03 0.06 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.274 -0.891 . . . . 10.0 109.638 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.53 ' CB ' ' O ' ' A' ' 9' ' ' LYS . 3.3 m 79.96 -73.36 0.06 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.504 -0.748 . . . . 10.0 109.586 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' O ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 62.59 127.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.126 -0.984 . . . . 10.0 109.612 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.437 ' O ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER 50.47 -179.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.197 -0.94 . . . . 10.0 109.497 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -149.98 -66.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 10.0 109.485 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.47 ' O ' HG22 ' A' ' 14' ' ' THR . 51.3 m -124.05 78.87 1.67 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 10.0 109.543 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -115.16 101.85 9.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.171 -0.956 . . . . 10.0 109.246 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 1.3 mtt85 -78.44 174.23 11.52 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.171 -0.956 . . . . 10.0 109.711 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.62 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 6.7 mmt-85 147.93 -57.96 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 107.853 -1.166 . . . . 10.0 107.853 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.62 ' HD3' ' HB2' ' A' ' 17' ' ' ARG . 36.7 Cg_endo -77.73 -24.24 8.89 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.384 2.056 . . . . 10.0 108.167 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -89.49 40.6 1.0 Allowed 'General case' 0 C--N 1.286 -2.18 0 CA-C-O 123.24 1.495 . . . . 10.0 110.518 -179.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -153.89 -43.06 0.09 Allowed 'General case' 0 C--N 1.251 -3.685 0 CA-C-N 113.67 -1.605 . . . . 10.0 109.009 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -77.38 2.0 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 117.854 -1.539 . . . . 10.0 109.939 -178.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' CA ' ' HB ' ' A' ' 29' ' ' ILE . 8.3 ptpt -101.94 5.78 40.99 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 106.828 -1.545 . . . . 10.0 106.828 177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.653 ' N ' ' HD3' ' A' ' 24' ' ' PRO . 55.8 m-85 45.06 68.01 3.66 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-O 123.397 1.57 . . . . 10.0 107.071 -179.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 40.2 Cg_endo -77.05 -173.54 1.82 Allowed 'Trans proline' 0 C--N 1.295 -2.27 0 C-N-CA 124.762 3.642 . . . . 10.0 110.947 -176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 66.12 29.92 75.89 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.65 -58.98 0.18 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.056 -1.218 . . . . 10.0 110.056 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.46 67.21 0.21 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.444 -1.862 . . . . 10.0 108.444 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -135.02 18.59 3.45 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.553 -0.969 . . . . 10.0 109.299 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.681 ' C ' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -54.78 -28.74 20.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.459 0.647 . . . . 10.0 109.368 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.696 ' O ' HG12 ' A' ' 30' ' ' VAL . 48.7 t -84.59 16.03 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 C-N-CA 118.459 -1.297 . . . . 10.0 110.538 -177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -141.39 -27.65 0.18 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.836 -1.173 . . . . 10.0 110.93 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -80.35 -19.88 68.1 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 117.777 -2.154 . . . . 10.0 108.929 178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' HA ' HD11 ' A' ' 36' ' ' LEU . 40.3 t -73.95 -11.17 14.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 105.512 -2.032 . . . . 10.0 105.512 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 21.5 m-85 -103.62 -16.15 15.59 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.872 -1.513 . . . . 10.0 107.073 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.902 HD12 ' HA2' ' A' ' 32' ' ' GLY . 30.7 mt -90.45 4.26 51.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.625 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 16.6 mt -76.79 -45.54 3.06 Favored Pre-proline 0 N--CA 1.486 1.361 0 CA-C-N 115.777 -0.647 . . . . 10.0 110.907 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.625 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 35.6 Cg_endo -78.22 -54.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.403 2.069 . . . . 10.0 110.281 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -87.44 23.51 1.88 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 10.0 109.879 -179.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -50.06 96.19 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.108 -0.995 . . . . 10.0 109.515 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 38' ' ' ARG . . . 44.61 89.86 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.33 179.31 6.62 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.544 2.163 . . . . 10.0 110.357 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.39 3.82 35.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 10.0 109.575 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -122.26 58.01 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 10.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 CA-C-O 117.966 -1.463 . . . . 10.0 109.506 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.48 -0.563 . . . . 10.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 90.9 m -157.98 -74.63 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 10.0 109.461 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -52.56 152.77 6.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.241 -0.912 . . . . 10.0 109.504 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 5' ' ' LYS . 35.4 Cg_endo -77.93 -2.99 13.08 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.646 2.231 . . . . 10.0 110.449 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 4' ' ' PRO . 14.9 mttm 61.44 79.68 0.27 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 10.0 109.43 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.97 134.15 12.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.629 2.219 . . . . 10.0 110.429 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.83 -90.04 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 10.0 109.42 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.09 99.75 0.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 10.0 109.416 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.728 ' HG3' HG22 ' A' ' 10' ' ' THR . 3.3 tttt -163.13 -88.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 10.0 109.535 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.728 HG22 ' HG3' ' A' ' 9' ' ' LYS . 0.6 OUTLIER 174.71 172.92 0.22 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.197 -0.939 . . . . 10.0 109.292 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -58.2 177.77 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 10.0 109.47 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.6 98.75 1.69 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 10.0 109.578 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -113.84 -63.71 1.41 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.333 -0.855 . . . . 10.0 109.34 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.763 HG23 ' O ' ' A' ' 14' ' ' THR . 8.8 t -141.14 81.29 1.78 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.392 -0.818 . . . . 10.0 109.34 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -47.39 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 10.0 109.622 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.635 ' O ' ' CB ' ' A' ' 17' ' ' ARG . 0.0 OUTLIER -80.15 -174.98 4.8 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.327 -0.858 . . . . 10.0 109.902 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.653 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 15.7 tpt180 124.49 -47.5 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 CA-C-N 115.238 -0.892 . . . . 10.0 108.606 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 37.4 Cg_endo -83.24 -30.3 0.92 Allowed 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.178 1.919 . . . . 10.0 108.556 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 24' ' ' PRO . 0.8 OUTLIER -89.37 44.8 1.23 Allowed 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.87 -1.514 . . . . 10.0 110.367 -179.305 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -157.26 -41.81 0.07 Allowed 'General case' 0 C--N 1.249 -3.773 0 CA-C-N 113.761 -1.563 . . . . 10.0 108.826 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.605 HG12 ' O ' ' A' ' 21' ' ' VAL . 84.7 t -77.45 2.42 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 C-N-CA 117.72 -1.592 . . . . 10.0 109.895 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 29' ' ' ILE . 8.6 ptpt -106.42 9.56 31.71 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.866 -1.531 . . . . 10.0 106.866 177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.64 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 61.7 m-85 41.87 69.89 1.92 Allowed Pre-proline 0 C--N 1.3 -1.567 0 CA-C-O 123.258 1.504 . . . . 10.0 107.491 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.602 ' HD3' ' N ' ' A' ' 23' ' ' PHE . 38.3 Cg_endo -75.85 -0.88 10.73 Favored 'Trans proline' 0 C--N 1.294 -2.332 0 C-N-CA 124.778 3.652 . . . . 10.0 110.812 -176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.2 -23.04 5.45 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.779 -1.728 . . . . 10.0 108.779 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.56 43.44 0.46 Allowed Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.634 -1.386 . . . . 10.0 109.634 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.9 -97.65 1.79 Allowed Glycine 0 N--CA 1.487 2.042 0 N-CA-C 109.774 -1.33 . . . . 10.0 109.774 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.822 ' O ' HG23 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -135.95 -33.67 0.84 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.368 -1.078 . . . . 10.0 110.954 -178.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.822 HG23 ' O ' ' A' ' 28' ' ' GLN . 0.7 OUTLIER 85.34 -12.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 108.934 -0.765 . . . . 10.0 108.934 -178.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.691 ' O ' HG12 ' A' ' 30' ' ' VAL . 61.5 t -98.04 18.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 35' ' ' LEU . . . -128.28 -23.34 1.27 Allowed Glycine 0 N--CA 1.486 1.995 0 C-N-CA 119.035 -1.555 . . . . 10.0 111.988 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 35' ' ' LEU . . . -82.8 -26.46 45.64 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 117.686 -2.197 . . . . 10.0 109.991 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.597 ' HB ' ' CE1' ' A' ' 34' ' ' TYR . 17.5 t -73.51 -9.83 13.31 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 105.922 -1.881 . . . . 10.0 105.922 175.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 12.6 m-85 -105.41 -15.65 14.96 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 113.86 -1.518 . . . . 10.0 106.907 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.894 HD12 ' HA2' ' A' ' 32' ' ' GLY . 10.1 mt -91.46 6.93 43.58 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 107.241 -1.392 . . . . 10.0 107.241 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.624 ' N ' ' HD2' ' A' ' 37' ' ' PRO . 19.4 mt -78.78 -45.22 1.88 Allowed Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 115.596 -0.729 . . . . 10.0 111.231 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 36' ' ' LEU . 36.7 Cg_endo -77.22 -100.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.089 1.859 . . . . 10.0 110.207 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.47 ' CG ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -94.72 -106.04 0.14 Allowed 'General case' 0 C--N 1.309 -1.181 0 O-C-N 120.768 -1.208 . . . . 10.0 109.461 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.4 OUTLIER -106.96 -17.15 14.26 Favored 'General case' 0 C--N 1.289 -2.028 0 O-C-N 121.345 -0.847 . . . . 10.0 109.346 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.6 78.34 1.22 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.353 -1.499 . . . . 10.0 109.353 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.401 ' HB2' ' CD1' ' A' ' 43' ' ' LEU . 35.6 Cg_endo -78.24 157.68 29.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.647 2.232 . . . . 10.0 110.542 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.5 104.28 14.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 10.0 109.413 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 41' ' ' PRO . 5.6 mp -118.71 61.15 0.79 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 10.0 109.517 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.449 -1.46 . . . . 10.0 109.449 -179.963 . . . . . . . . 0 0 . 1 stop_ save_